Literature DB >> 26981214

Diagnosis and management of patients with asymptomatic severe aortic stenosis.

Minako Katayama1, Hari P Chaliki1.   

Abstract

Aortic stenosis (AS) is a disease that progresses slowly for years without symptoms, so patients need to be carefully managed with appropriate follow up and referred for aortic valve replacement in a timely manner. Development of symptoms is a clear indication for aortic valve intervention in patients with severe AS. The decision for early surgery in patients with asymptomatic severe AS is more complex. In this review, we discuss how to identify high-risk patients with asymptomatic severe AS who may benefit from early surgery.

Entities:  

Keywords:  Aortic stenosis; Asymptomatic; Diagnosis; Management; Treatment

Year:  2016        PMID： 26981214      PMCID： PMC4766269          DOI： 10.4330/wjc.v8.i2.192

Source DB:  PubMed          Journal:  World J Cardiol


  64 in total

1.  Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.

Authors:  Luis M Moura; Sandra F Ramos; José L Zamorano; Isabel M Barros; Luis F Azevedo; Francisco Rocha-Gonçalves; Nalini M Rajamannan
Journal:  J Am Coll Cardiol       Date:  2007-01-22       Impact factor: 24.094

2.  Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing.

Authors:  M C Amato; P J Moffa; K E Werner; J A Ramires
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

3.  Value of exercise testing to evaluate the indication for surgery in asymptomatic patients with valvular aortic stenosis.

Authors:  Domenico Alborino; Jacques Lars Hoffmann; Pierre Claude Fournet; Antoine Bloch
Journal:  J Heart Valve Dis       Date:  2002-03

4.  Improvement in early diastolic filling dynamics after aortic valve replacement.

Authors:  I C Gilchrist; H L Waxman; P B Kurnik
Journal:  Am J Cardiol       Date:  1990-11-01       Impact factor: 2.778

5.  Low-gradient, low-flow severe aortic stenosis with preserved left ventricular ejection fraction: characteristics, outcome, and implications for surgery.

Authors:  Christophe Tribouilloy; Dan Rusinaru; Sylvestre Maréchaux; Anne-Laure Castel; Nicolas Debry; Julien Maizel; Romuald Mentaverri; Said Kamel; Michel Slama; Franck Lévy
Journal:  J Am Coll Cardiol       Date:  2015-01-06       Impact factor: 24.094

6.  Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.

Authors:  Gian M Novaro; Ronit Katz; Ronnier J Aviles; John S Gottdiener; Mary Cushman; Bruce M Psaty; Catherine M Otto; Brian P Griffin
Journal:  J Am Coll Cardiol       Date:  2007-10-29       Impact factor: 24.094

7.  Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS).

Authors:  Anand Chockalingam; S Venkatesan; T Subramaniam; V Jagannathan; S Elangovan; R Alagesan; G Gnanavelu; Smrita Dorairajan; B P Krishna; V Chockalingam
Journal:  Am Heart J       Date:  2004-04       Impact factor: 4.749

8.  Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function.

Authors:  Kevin D O'Brien; Xue-Qiao Zhao; David M Shavelle; Michael T Caulfield; Rebecca A Letterer; Samir R Kapadia; Jeffrey L Probstfield; Catherine M Otto
Journal:  J Investig Med       Date:  2004-04       Impact factor: 2.895

9.  Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival.

Authors:  Zeineb Hachicha; Jean G Dumesnil; Peter Bogaty; Philippe Pibarot
Journal:  Circulation       Date:  2007-05-28       Impact factor: 29.690

10.  Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis.

Authors:  Marc R Dweck; Sanjiv Joshi; Timothy Murigu; Francisco Alpendurada; Andrew Jabbour; Giovanni Melina; Winston Banya; Ankur Gulati; Isabelle Roussin; Sadaf Raza; Nishant A Prasad; Rick Wage; Cesare Quarto; Emiliano Angeloni; Simone Refice; Mary Sheppard; Stuart A Cook; Philip J Kilner; Dudley J Pennell; David E Newby; Raad H Mohiaddin; John Pepper; Sanjay K Prasad
Journal:  J Am Coll Cardiol       Date:  2011-09-13       Impact factor: 24.094
View more
  4 in total

Review 1.  Asymptomatic Severe Aortic Stenosis: Contemporary Evaluation and Management.

Authors:  Mohamed Salah Abdelghani; Sundus Sardar; Abdelhaleem Shawky Hamada
Journal:  Heart Views       Date:  2022-05-16

2.  Management of patients with severe aortic stenosis in the TAVI-era: how recent recommendations are translated into clinical practice.

Authors:  Alexander Lauten; Tanja K Rudolph; David Messika-Zeitoun; Jeetendra Thambyrajah; Antonio Serra; Eberhard Schulz; Norbert Frey; Jiri Maly; Marco Aiello; Guy Lloyd; Alessandro Santo Bortone; Alberto Clerici; Georg Delle-Karth; Johannes Rieber; Ciro Indolfi; Massimo Mancone; Loic Belle; Martin Arnold; Berto J Bouma; Matthias Lutz; Cornelia Deutsch; Jana Kurucova; Martin Thoenes; Peter Bramlage; Richard Paul Steeds
Journal:  Open Heart       Date:  2021-01

3.  Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry.

Authors:  Josef Veselka; Lothar Faber; Max Liebregts; Robert Cooper; Jaroslav Januska; Jan Krejci; Thomas Bartel; Maciej Dabrowski; Peter Riis Hansen; Vibeke Marie Almaas; Hubert Seggewiss; Dieter Horstkotte; Radka Adlova; Henning Bundgaard; Jurriën Ten Berg; Rodney Hilton Stables; Morten Kvistholm Jensen
Journal:  J Am Heart Assoc       Date:  2017-05-16       Impact factor: 5.501

4.  Glasgow Prognostic Score as a Marker of Mortality after TAVI.

Authors:  Ozge Ozcan Abacioglu; Nermin Yildiz Koyunsever; Salih Kilic; Arafat Yildirim; Ibrahim Halil Kurt
Journal:  Braz J Cardiovasc Surg       Date:  2021-12-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.